Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3998
Source ID: NCT00907881
Associated Drug: Sulfonylurea
Title: The OBSTACLE Hypoglycemia Study (MK-0000-158)
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT00907881/results
Conditions: Type 2 Diabetes
Interventions: DRUG: Sulfonylurea
Outcome Measures: Primary: Correlation Between HbA1c Values at Week 12 and Hypoglycemia Scores, Coefficient of correlation was measured using a linear regression analysis for the association between two variables, HbA1c values at Week 12 and hypoglycemia scores. A negative correlation coefficient indicates that as one value increases the other value decreases, and vice versa., Week 12 | Secondary: Hypoglycemia Symptom Score by Sub-group (Demographic/Disease Parameters), Sub-group analyses of mean hypoglycemia symptom score. Participants were grouped based on gender, age, hypoglycemia severity, body mass index, duration of diabetes, and number of oral hypoglycemic agents. Hypoglycemia symptom score (measured by Stanford Hypoglycemia Questionnaire) is a score on a scale with a possible range of 0 (best) to 7 (worst). The questionnaire was administered by the physician at Week 12., Week 12|Correlation Between HbA1c Values at Week 12 and Hypoglycemia Scores by Sub-group (Demographic/Disease Parameters), Sub-group analyses based on Karl pearson coefficient of correlation for HbA1c values at Week 12 and hypoglycemia score. Participants were grouped based on gender, age, body mass index, and duration of diabetes. A negative correlation coefficient indicates that as one value increases the other value decreases, and vice versa., Week 12|Correlation Between HbA1c Values at Baseline and Hypoglycemia Scores at Week 12, Coefficient of correlation as measured using linear regression analysis for association between two variables, HbA1c values at baseline and hypoglycemia scores. A positive correlation coefficient indicates that as one value increases the other value increases, or as as one value decreases the other value decreases., Baseline and Week 12
Sponsor/Collaborators: Sponsor: Merck Sharp & Dohme LLC
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 1069
Study Type: OBSERVATIONAL
Study Designs: Observational Model: |Time Perspective: p
Start Date: 2009-08
Completion Date: 2010-05
Results First Posted: 2011-11-24
Last Update Posted: 2015-04-21
Locations:
URL: https://clinicaltrials.gov/show/NCT00907881